2
Clinical Trials associated with JNJ-69095897A 3-Part, Randomized, Placebo-controlled, Double-blind, Single Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-69095897 in Healthy Participants
The purpose of this study is to investigate the safety and tolerability of JNJ-69095897 versus placebo and to characterize the pharmacokinetic (PK) of JNJ-69095897 in blood, plasma, cerebrospinal fluid (CSF) and urine after single or divided oral dose administration in healthy participants.
/ CompletedNot Applicable A 3-Part, Randomized, Placebo-controlled, Double-blind, Single Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ69095897 in Healthy Participants - A*Study to*Investigate*Safety and*Pharmacokinetics of JNJ-69095897
100 Clinical Results associated with JNJ-69095897
100 Translational Medicine associated with JNJ-69095897
100 Patents (Medical) associated with JNJ-69095897
100 Deals associated with JNJ-69095897